1,570
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms

, , , , , & show all
Pages 863-869 | Received 26 Dec 2016, Accepted 19 Aug 2017, Published online: 03 Sep 2017

References

  • Lencioni R, Crocetti L. (2012). Local-regional treatment of hepatocellular carcinoma. Radiology 262:43–58.
  • European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. (2012). EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–43.
  • de Lope CR, Tremosini S, Forner A, et al. (2012). Management of HCC. J Hepatol 56(Suppl 1):S75–S87.
  • Rhim H, Goldberg SN, Dodd GD, et al. (2001). Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 21:S17–S35.
  • Mazzaferro V, Lencioni R, Majno P. (2014). Early hepatocellular carcinoma on the procrustean bed of ablation resection and transplantation. Semin Liv Dis 34:415–26.
  • Amabile C, Ahmed M, Solbiati L, et al. (2017). Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia 33:34–42.
  • Potretzke TA, Ziemlewicz TJ, Hinshaw JL, et al. (2016). Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center. J Vasc Interv Radiol 27:631–8.
  • Hoffmann R, Rempp H, Erhard L, et al. (2013). Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology 268:89–97.
  • Mulier S, Ni Y, Jamart J, et al. (2005). Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–71.
  • Howenstein MJ, Sato KT. (2010). Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol 27:285–95.
  • Lencioni R, Llovet JM. (2010). Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60.
  • Lencioni R. (2013). New data supporting modified RECIST (mRECIST) for hepatocellular carcinoma. Clin Cancer Res 19:1312–14.
  • Leoni CJ, Potter JE, Rosen MP, et al. (2001). Classifying complications of interventional procedures: a survey of practicing radiologists. J Vasc Interv Radiol 12:55–9.
  • Nishimura M, Nouso K, Kariyama K, et al. (2012). Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma. Acta Med Okayama 66:279–84.
  • Song I, Rhim H, Lim HK, et al. (2009). Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630–40.
  • Hakimé A, Tselikas L, Otmezguine Y, et al. (2015). Artificial ascites for pain relief during microwave ablation of subcapsular liver tumors. Cardiovasc Intervent Radiol 38:1557–62.
  • Kondo Y, Yoshida H, Shiina S, et al. (2006). Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg 93:1277–82.
  • Kitchin D, Lubner M, Ziemlewicz T, et al. (2014). Microwave ablation of malignant hepatic tumours: intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection. Int J Hyperthermia 30:299–305.
  • Francica G, Meloni MF, de Sio I, et al. (2016). Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy. Eur J Radiol 85:739–43.
  • de Baère T, Dromain C, Lapeyre M, et al. (2005). Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology 236:666–70.
  • Zhang D, Liang P, Yu X, et al. (2013). The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study. Int J Hyperthermia 29:663–70.
  • Iwai S, Sakaguchi H, Fujii H, et al. (2012). Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome. Hepatogastroenterology 59:546–50.
  • Rhim H, Lim HK. (2009). Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging34:371–80.
  • Basile A, Calcara G, Montineri A, et al. (2008). Application of a new combined guiding technique in RF ablation of subphrenic liver tumors. Eur J Radiol 66:321–4.
  • Brennan DD, Ganguli S, Brecher CW, Goldberg SN. (2008). Thinking outside the abdominal box: safe use of the epi-pericardial fat pad window for percutaneous radiofrequency ablation of hepatic dome tumors. J Vasc Interv Radiol 19:133–6.
  • Carberry GA, Nocerino E, Mason PJ, et al. (2017). Pulmonary microwave ablation near the heart: antenna positioning can mitigate cardiac complications in a porcine model. Radiology 282:892–902.
  • Ni JY, Liu SS, Xu LF, et al. (2013). Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 139:653–9.
  • Ginsburg M, Zivin SP, Wroblewski K, et al. (2015). Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation. J Vasc Interv Radiol 26:330–41.
  • Iezzi R, Pompili M, Posa A, et al. (2014). Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art. World J Gastroenterol 22:1935–42.
  • Iezzi R, Pompili M, Gasbarrini A, Bonomo L. (2014). Sequential or combined treatment? That is the question. Radiology 272:612–13.
  • Liu C, Liang P, Liu F, et al. (2011). MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Int J Hyperthermia 27:654–62.
  • Facciorusso A, Di Maso M, Muscatiello N. (2016). Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 32:339–44.
  • Xu Y, Shen Q, Wang N, et al. (2017). Percutaneous microwave ablation of 5-6 cm unresectable hepatocellular carcinoma: local efficacy and long-term outcomes. Int J Hyperthermia 33:247–54.
  • Meloni MF, Chiang J, Laeseke PF, et al. (2017). Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia 33:15–24.
  • Li X, Zhang L, Fan W, et al. (2011). Comparison of microwave ablation and multipolar radiofrequency ablation, both using a pair of internally cooled interstitial applicators: results in ex vivo porcine livers. Int J Hyperthermia 27:240–8.
  • Vogl TJ, Hagar A, Nour-Eldin NA, et al. (2016). High-frequency versus low-frequency microwave ablation in malignant liver tumours: evaluation of local tumour control and survival. Int J Hyperthermia 32:868–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.